RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in…
$5.32-1.12%
报价 2026-11-13
市值
$223.1M
EV
$254.8M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -59.4%
$4.51$13.09
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RXSTRxSight, Inc. | $223.1M | -1.1% | -1.7% | 76.6% | – | – | 12.0x | |
| BFLYButterfly Network, Inc. | $1.63B | -8.8% | +36.0% | 73% | – | – | – | 高增长 |
| KIDSOrthoPediatrics Corp. | $844.7M | -0.7% | +15.6% | 73.8% | – | 364.7x | 253.5x | GARP |
| DCTHDelcath Systems, Inc. | $714.9M | -3.9% | +32.9% | 128.7% | 113.9x | 77.0x | 35.0x | 高增长 |
| TCMDTactile Systems Technology, Inc. | $600.6M | -0.0% | +13.4% | 75.2% | 31.1x | 13.8x | 20.7x | GARP |
| DMACDiaMedica Therapeutics Inc. | $474.3M | -5.8% | +10700.0% | 0% | – | – | – | |
| CERSCerus Corporation | $400.9M | +2.3% | +10.4% | 52.1% | – | 226.7x | – | GARP |
| TMCITreace Medical Concepts, Inc. | $345.5M | -1.3% | -1.9% | 79.6% | – | – | – | |
| NPCENeuroPace, Inc. | $260.5M | -37.1% | +5.5% | 77.2% | – | – | – | |
| 同行中位数 | – | – | +14.5% | 74.5% | 72.5x | 151.9x | 35.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。